Matthew Moschner, CEO and President of Cognex Corp, filed a Form 4 on August 12, 2026, reporting stock option exercises and share sales totaling 28,562 shares of Common Stock executed on August 11, 2026, all under a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Option exercises: Moschner exercised four separate non-qualified stock option tranches on August 11, 2026, acquiring a combined 16,600 shares at exercise prices of $56.44, $51.49, $40.71, and $42.84 per share.
  • Open market sales: A total of 24,962 shares were disposed of on August 11, 2026, including 16,600 shares sold at prices of $65.36 and $63.6158/$63.6102 per share, and an additional 8,362 shares sold at $63.621 per share.
  • Resulting ownership: Following all reported transactions, Moschner directly beneficially owned 10,884 shares of Common Stock.
  • Rule 10b5-1 plan: According to the filing, all option exercises and share sales were effected pursuant to a trading plan adopted by Moschner under Rule 10b5-1 of the Securities Exchange Act of 1934.
  • Remaining derivative holdings: The filing reports Moschner retains numerous non-qualified stock options and restricted stock units, including options covering 279,070 shares at an exercise price of $27.99 expiring 05/05/2035.

Cognex CEO Reports Multi-Tranche Option Exercise and Share Disposal on August 11, 2026

According to the Form 4 filed with the SEC on August 12, 2026, Matthew Moschner, who serves as CEO and President of Cognex Corp (NASDAQ:CGNX) and is also identified as a Director, carried out a series of transactions on August 11, 2026. The filing records four "M" coded transactions, indicating exercises of non-qualified stock options, converting a combined 16,600 shares into Common Stock at exercise prices ranging from $40.71 to $56.44 per share.

Coinciding with each option exercise, the filing records corresponding "S" coded disposals. Three tranches of 1,600, 4,000, and 4,000 shares were sold at $65.36 per share, while 4,000 shares were sold at $63.6158 and 7,000 shares at $63.6102 per share. Additionally, 8,362 shares were disposed of in an open market sale at $63.621 per share, coded as transaction (2). The filing states that all exercises were made pursuant to a Rule 10b5-1 trading plan, and the additional open market sale was likewise made pursuant to such a plan.

After all reported transactions, Moschner's direct beneficial ownership in Common Stock stood at 10,884 shares, according to the filing. Table II of the filing also lists a substantial portfolio of remaining non-qualified stock options across multiple grant dates and exercise prices, as well as three tranches of restricted stock units covering 5,071, 20,339, and 56,928 shares of Common Stock, respectively, with expiration dates ranging through February 2029.

What Was Disclosed

The filing discloses that Cognex Corp's CEO and President Matthew Moschner exercised stock options covering 16,600 shares and sold a total of 24,962 shares of Common Stock on August 11, 2026, all under a pre-established Rule 10b5-1 trading plan, leaving him with 10,884 directly held shares.